Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.
Nobivac Puppy DP 5x1
Puppy DP provides protection against Canine Distemper (CVD) and Canine Parvovirus (CPV) disease.
Nobivac Puppy DP 5x1 doses
- Provides broad coverage against CPV
- Protects against all known field strains of parvovirus
- High antigenic mass (titer), low passage parvovirus vaccine
- High titer distemper fraction
- Overrides maternal antibodies in young puppies
- Protects against the most common, deadly diseases in puppies – canine distemper and parvovirosis
Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper and canine parvovirus.
Recommended for use in healthy dogs 6 weeks of age or older.
|Registration number||REG NL 9484|
|Legal status of supply||UDD|
|Withdrawal period||0 days|
|Expiry date||Sep 30, 2022|
|Units per outer box||0|
Per 1 ml dose: Lyophilisate
* CCID50: Cell Culture Infective Dose 50%
Instructions for use
Transfer contents of the sterile diluent vial to the Nobivac Puppy-DP vial aseptically. Mix gently until dissolved. Inject one dose (1mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat dose 3 to 4 weeks later. Two doses are required for primary immunization.
For mixed administration, Nobivac puppy DP can be administered together with the Nobivac vaccine against leptospirosis (caused by all or some of the following serovars: L. interrogans serogroup Canicola serovar Canicola, L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni, L. interrogans serogroup Australis serovar Bratislava and L.kirschneri serogroup Grippotyphosa serovar Bananal / Liangguang). Administer the mixed vaccines by subcutaneous injection.
In very rare cases, a hypersensitivity reaction with symptoms such as lethargy, edema of the head, pruritus, vomiting, diarrhea, dyspnoea or collapse may occur after vaccination. In most cases this type of reaction is mild, transient and self-limiting. However, appropriate treatment may be required. In very rare cases, a local reaction, e.g. local swelling, may occur at the injection site. The frequency of side effects is defined as follows:
- Very common (more than 1 in 10 animals have side effect (s) for the duration of one treatment)
- Often (1 to 10 out of 100 animals)
- Sometimes (1 to 10 animals in 1,000)
- Rare (1 to 10 animals in 10,000)
- Very rare (less than 1 animal in 10,000, including isolated reports).